Tobacco News and Research RSS Feed - Tobacco News and Research

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use. [More]
Researchers find molecule that irreversibly interferes with activity of mutated cancer gene

Researchers find molecule that irreversibly interferes with activity of mutated cancer gene

UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors. [More]
Hardship exemptions allow some to continue to buy coverage on health law's marketplaces

Hardship exemptions allow some to continue to buy coverage on health law's marketplaces

Elsewhere, the San Jose Mercury News examines who can opt out of the health law's mandate to have insurance on religious grounds. [More]
Cancer researchers find molecule that irreversibly interferes with KRAS gene

Cancer researchers find molecule that irreversibly interferes with KRAS gene

UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors. [More]
Nicotine, cotinine can potentially inhibit DNA damage caused by NNK in tobacco smoke

Nicotine, cotinine can potentially inhibit DNA damage caused by NNK in tobacco smoke

A new in vitro study has revealed that nicotine and cotinine, a metabolite of nicotine, can potentially inhibit DNA damage caused by a certain carcinogen in smoke. [More]
New York City moves forward to implement law banning tobacco discounting schemes

New York City moves forward to implement law banning tobacco discounting schemes

Tobacco companies have abandoned their legal challenge to New York City's innovative new law prohibiting tobacco discounting schemes, as they chose not to appeal a federal court ruling that upheld the law. The deadline for the tobacco companies to appeal was July 18. [More]
Mexico, US sign statement of intent to promote safety of fresh agricultural products

Mexico, US sign statement of intent to promote safety of fresh agricultural products

The U.S. Food and Drug Administration and the government of Mexico's National Service for Agro-Alimentary Public Health, Safety and Quality (SENASICA) and Federal Commission for the Protection from Sanitary Risks (COFEPRIS) signed a statement of intent forming a partnership to promote the safety of fresh and minimally processed agricultural products. [More]
Direct medical costs projected to increase to $49 billion annually by 2020

Direct medical costs projected to increase to $49 billion annually by 2020

The American College of Chest Physicians announced today the Online First publication of 'Total and State-Specific Medical and Absenteeism Costs of Chronic Obstructive Pulmonary Disease Among Adults Aged ≥18 Years in the United States for 2010 and Projections Through 2020' in the journal CHEST. [More]
Caffeine intake may aggravate hot flashes and night sweats in postmenopausal women

Caffeine intake may aggravate hot flashes and night sweats in postmenopausal women

A new Mayo Clinic study, published online today by the journal Menopause, found an association between caffeine intake and more bothersome hot flashes and night sweats in postmenopausal women. [More]
FDA approves Targiniq ER to treat severe pain

FDA approves Targiniq ER to treat severe pain

Today, the U.S. Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), an extended-release/long-acting (ER/LA) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. [More]
Zydelig gets FDA approval for treatment of patients with three types of blood cancers

Zydelig gets FDA approval for treatment of patients with three types of blood cancers

The U.S. Food and Drug Administration today approved Zydelig (idelalisib) to treat patients with three types of blood cancers. [More]
Highlights: Florida officials crack down on direct Medicaid marketing; a wellness plan in Washington state breaks the mold

Highlights: Florida officials crack down on direct Medicaid marketing; a wellness plan in Washington state breaks the mold

[Florida] health officials are taking a cue from past problems and are banning health insurance companies from marketing their plans directly to Medicaid consumers as the state is rolling out a massive overhaul by transitioning millions into managed care. Insurance companies are allowed to market to consumers under the contracts, but only if the state gives prior approval (Kennedy, 7/22). [More]
First Edition: July 22, 2014

First Edition: July 22, 2014

Reporting for Kaiser Health News, Susan Jaffe writes: "Medicare officials have allowed patients at dozens of hospitals participating in pilot projects across the country to be exempted from the controversial requirement that limits nursing home coverage to seniors admitted to a hospital for at least three days. [More]
BP variability may be ‘CV risk integrator’

BP variability may be ‘CV risk integrator’

Increased variability in blood pressure may be an indicator of overall cardiovascular risk rather than being a risk factor per se, suggest researchers. [More]
First Edition: July, 21, 2014

First Edition: July, 21, 2014

Today's headlines include a story about an effort by regulators to widen insurer networks, as well as a range of other health policy developments. [More]
FDA approves Ruconest for treatment of acute attacks in adolescent patients with HAE

FDA approves Ruconest for treatment of acute attacks in adolescent patients with HAE

The U.S. Food and Drug Administration yesterday approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE). [More]
Oral Cancer and Cody Kiser partner at upcoming Snake River Stampede Rodeo

Oral Cancer and Cody Kiser partner at upcoming Snake River Stampede Rodeo

While the world of rodeo has been the realm of sponsorship by the tobacco industry for decades, The Oral Cancer Foundation today takes a stand and introduces their new spokesperson, Cody Kiser; a rodeo cowboy who will be debuting his partnership with the foundation at the upcoming Snake River Stampede Rodeo in Nampa, ID. [More]
Research highlights potential cancer risk in non-smokers

Research highlights potential cancer risk in non-smokers

Research led by the University of York has highlighted the potential cancer risk in non-smokers - particularly young children - of tobacco smoke gases and particles deposited to surfaces and dust in the home. [More]
Smoking may increase suicide risk

Smoking may increase suicide risk

Cigarette smokers are more likely to commit suicide than people who don't smoke, studies have shown. This reality has been attributed to the fact that people with psychiatric disorders, who have higher suicide rates, also tend to smoke. [More]
UN Member States reaffirm commitment to reduce avoidable burden of NCDs

UN Member States reaffirm commitment to reduce avoidable burden of NCDs

UN Member States have reaffirmed their commitment to take bold measures to reduce the avoidable burden of noncommunicable diseases (NCDs). These ailments, including heart disease and stroke, cancer, diabetes and lung disease kill 38 million people every year, many of them before they reach the age of 70. [More]